Divya Arora
Research Subjects
Research Interests
Divya Arora has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Sundeep Jaglan
Fermentation & Microbial Biotechnology Division, CSIR-Indian Institute of Integrative Medicine, Jammu, India
7 shared publications - Prasoon Gupta
Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh 201002, India; Natural Products and Medicinal Chemistry Division, CSIR - Indian Institute of Integrative Medicine, Canal Road, Jammu 180001, India
2 shared publications - Ravi Shankar
Natural Products and Medicinal Chemistry Division, CSIR-Indian Institute of Integrative Medicine, Jammu180001, India
2 shared publications - Vidushi Abrol
Fermentation and Microbial Biotechnology Division, Indian Institute of Integrative Medicine (CSIR), Jammu 180001, India
2 shared publications Ajai Prakash Gupta
Quality Control & Quality Assurance Division, CSIR-Indian Institute of Integrative Medicine, Canal Road, Jammu 180001, India
1 shared publicationAmit Kumar
Instrumentation Division, CSIR-Indian Institute of Integrative Medicine, Jammu 180001, India
1 shared publication
Latest Publications
- 11 November 2026
- Published by Wiley in Comprehensive Reviews in Food Science and Food Safety
- Vol. 25 (6)
Nano‐Enabled Postbiotics in Functional Foods: Stability Challenges, Gastrointestinal Fate, and Translational Perspectives
The increasing demand for preventive and personalized nutrition has driven rapid growth in functional food development. These foods are designed not only to provide basic nutrition but also to deliver health‐promoting bioactive compounds at specific sites. Postbiotics comprise nonviable microbial cells, cell components, and microbial metabolites. They have emerged as promising alternatives to live probiotics because of their improved safety, stability, and well‐defined biological functions. These components can support epithelial barrier integrity, metabolic regulation, and immune modulation. However, their application in functional foods remains limited by poor stability, gastrointestinal (GI) degradation, food‐matrix interactions, and low bioavailability following oral administration. This review discusses the major physicochemical and biological barriers affecting postbiotic stability and functionality. These include thermal degradation, pH instability, enzymatic breakdown, food‐matrix interactions, and storage‐related losses. It also highlights nano‐enabled delivery systems for improving postbiotic delivery. The main systems include liposomes, polymeric nanoparticles, nanogels, nanoemulsions, and solid lipid nanoparticles. Among these, nanoemulsions may offer comparatively greater translational promise for food applications because of their established processing, scalability, and compatibility with liquid and semisolid food matrices. Although the suitability of nanoemulsions depends on postbiotic properties and remains constrained by interfacial instability, oxidation, and food‐matrix interactions. These systems can improve protection, controlled release, GI targeting, and epithelial uptake. However, regulatory uncertainty, scale‐up challenges, economic constraints, and limited clinical evidence continue to hinder practical application. Future progress will depend on standardized characterization methods, long‐term clinical validation, comprehensive safety assessment, scalable manufacturing, regulatory harmonization, and commercialization.
- 11 November 2026
- Published by Wiley in Comprehensive Reviews in Food Science and Food Safety
- Vol. 25 (6)
Nano‐Enabled Postbiotics in Functional Foods: Stability Challenges, Gastrointestinal Fate, and Translational Perspectives
The increasing demand for preventive and personalized nutrition has driven rapid growth in functional food development. These foods are designed not only to provide basic nutrition but also to deliver health‐promoting bioactive compounds at specific sites. Postbiotics comprise nonviable microbial cells, cell components, and microbial metabolites. They have emerged as promising alternatives to live probiotics because of their improved safety, stability, and well‐defined biological functions. These components can support epithelial barrier integrity, metabolic regulation, and immune modulation. However, their application in functional foods remains limited by poor stability, gastrointestinal (GI) degradation, food‐matrix interactions, and low bioavailability following oral administration. This review discusses the major physicochemical and biological barriers affecting postbiotic stability and functionality. These include thermal degradation, pH instability, enzymatic breakdown, food‐matrix interactions, and storage‐related losses. It also highlights nano‐enabled delivery systems for improving postbiotic delivery. The main systems include liposomes, polymeric nanoparticles, nanogels, nanoemulsions, and solid lipid nanoparticles. Among these, nanoemulsions may offer comparatively greater translational promise for food applications because of their established processing, scalability, and compatibility with liquid and semisolid food matrices. Although the suitability of nanoemulsions depends on postbiotic properties and remains constrained by interfacial instability, oxidation, and food‐matrix interactions. These systems can improve protection, controlled release, GI targeting, and epithelial uptake. However, regulatory uncertainty, scale‐up challenges, economic constraints, and limited clinical evidence continue to hinder practical application. Future progress will depend on standardized characterization methods, long‐term clinical validation, comprehensive safety assessment, scalable manufacturing, regulatory harmonization, and commercialization.
- 29 January 2018
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1421 (1) , 5-18
Therapeutic applications of betulinic acid nanoformulations
Betulinic acid (BA), a naturally occurring plant‐derived pentacyclic triterpenoid, has gained attention in recent years owing to its broad‐spectrum biological and medicinal properties. Despite the pharmacological activity of BA, it has been associated with some drawbacks, such as poor aqueous solubility and short half‐life in vivo, which limit therapeutic application. To solve these problems, much work in recent years has focused on enhancing BA's aqueous solubility, half‐life, and efficacy by using nanoscale drug delivery systems. Several different kinds of nanoscale delivery systems—including polymeric nanoparticles, magnetic nanoparticles, liposomes, polymeric conjugates, nanoemulsions, cyclodextrin complexes, and carbon nanotubes—have been developed for the delivery of BA. Here, we focus on the recent developments of novel nanoformulations used to deliver BA in order to improve its efficacy.
- 29 January 2018
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1421 (1) , 5-18
Therapeutic applications of betulinic acid nanoformulations
Betulinic acid (BA), a naturally occurring plant‐derived pentacyclic triterpenoid, has gained attention in recent years owing to its broad‐spectrum biological and medicinal properties. Despite the pharmacological activity of BA, it has been associated with some drawbacks, such as poor aqueous solubility and short half‐life in vivo, which limit therapeutic application. To solve these problems, much work in recent years has focused on enhancing BA's aqueous solubility, half‐life, and efficacy by using nanoscale drug delivery systems. Several different kinds of nanoscale delivery systems—including polymeric nanoparticles, magnetic nanoparticles, liposomes, polymeric conjugates, nanoemulsions, cyclodextrin complexes, and carbon nanotubes—have been developed for the delivery of BA. Here, we focus on the recent developments of novel nanoformulations used to deliver BA in order to improve its efficacy.
- Open Access
- 30 December 2017
- Published by Oxford University Press (OUP) in Journal of Applied Microbiology
- Vol. 124 (3) , 730-739
Bacillus amyloliquefaciens induces production of a novel blennolide K in coculture of Setophoma terrestris
Aims The discovery of known bioactive chemical leads from microbial monocultures hinders the efficiency of drug discovery programmes. Therefore, in recent years, the use of fungal–bacterial coculture experiments has gained considerable attention due to their ability to generate new bioactive leads. In this work, fungal strain Setophoma terrestris was cocultured with Bacillus amyloliquifaciens to discover novel bioactive compounds. Materials and Methods The bioactive methanolic coculture extract was chosen for the isolation of compounds by chromatographic methods. The isolated compounds were characterized by NMR and mass spectrometric techniques. Conclusion Coculture extract has resulted in the production of five blennolides. The novel compound, blennolide K was found active against PC-3 (prostate) and MCF-7 (breast) cell lines with an IC50 value of 3·7 ± 0·6 and 4·8 ± 0·4 μmol l−1 respectively. Furthermore, the nuclear morphology study in PC-3 cells after treatment with blennolide K, demonstrated chromatin condensation, formation of apoptotic bodies and shrinkage of cells. Significance and Impact of the Study To our knowledge, only few studies have reported the induction of bioactive compounds by coculture having long-distance inhibition morphology. This is principally due to the low occurrences of such morphology. Our study demonstrates the impact of coculture on production of new chemical leads in drug discovery programmes.
- 30 December 2017
- Published by Oxford University Press (OUP) in Journal of Applied Microbiology
- Vol. 124 (3) , 730-739
Open AccessBacillus amyloliquefaciens induces production of a novel blennolide K in coculture of Setophoma terrestris
Aims The discovery of known bioactive chemical leads from microbial monocultures hinders the efficiency of drug discovery programmes. Therefore, in recent years, the use of fungal–bacterial coculture experiments has gained considerable attention due to their ability to generate new bioactive leads. In this work, fungal strain Setophoma terrestris was cocultured with Bacillus amyloliquifaciens to discover novel bioactive compounds. Materials and Methods The bioactive methanolic coculture extract was chosen for the isolation of compounds by chromatographic methods. The isolated compounds were characterized by NMR and mass spectrometric techniques. Conclusion Coculture extract has resulted in the production of five blennolides. The novel compound, blennolide K was found active against PC-3 (prostate) and MCF-7 (breast) cell lines with an IC50 value of 3·7 ± 0·6 and 4·8 ± 0·4 μmol l−1 respectively. Furthermore, the nuclear morphology study in PC-3 cells after treatment with blennolide K, demonstrated chromatin condensation, formation of apoptotic bodies and shrinkage of cells. Significance and Impact of the Study To our knowledge, only few studies have reported the induction of bioactive compounds by coculture having long-distance inhibition morphology. This is principally due to the low occurrences of such morphology. Our study demonstrates the impact of coculture on production of new chemical leads in drug discovery programmes.
- 1 December 2017
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 27 (23) , 5126-5130
Preparation, characterization and cytotoxic evaluation of bovine serum albumin nanoparticles encapsulating 5-methylmellein: A secondary metabolite isolated from Xylaria psidii
- 1 December 2017
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 27 (23) , 5126-5130
Preparation, characterization and cytotoxic evaluation of bovine serum albumin nanoparticles encapsulating 5-methylmellein: A secondary metabolite isolated from Xylaria psidii
- 21 August 2017
- Published by Springer Nature in Environmental Chemistry Letters
- Vol. 16 (1) , 35-41
Therapeutic applications of resveratrol nanoformulations
- 21 August 2017
- Published by Springer Nature in Environmental Chemistry Letters
- Vol. 16 (1) , 35-41
Therapeutic applications of resveratrol nanoformulations
- 1 August 2016
- Published by Elsevier in Trends in Food Science & Technology
- Vol. 54, 114-126
Nanocarriers based delivery of nutraceuticals for cancer prevention and treatment: A review of recent research developments
- 1 August 2016
- Published by Elsevier in Trends in Food Science & Technology
- Vol. 54, 114-126
Nanocarriers based delivery of nutraceuticals for cancer prevention and treatment: A review of recent research developments
- 19 April 2016
- Published by Taylor & Francis in Journal of Drug Targeting
- Vol. 25 (1) , 1-16
Polysaccharides based nanomaterials for targeted anti-cancer drug delivery
Polysaccharides, an important class of biological polymers, are effectively bioactive, non-toxic, hydrophilic, biodegradable and offer a wide diversity in structure and properties. These can be easily modified chemically and biochemically to enhance the bioadhesion with biological tissues, better stability and can able to improve bioavailability of drugs. Most of the chemotherapeutic drugs have a narrow therapeutic index, slow drug delivery systems and poor water solubility that usually proves toxic to human bodies. The inherent biocompatibility of these biopolymers have shown enhancement of solubility of some chemotherapeutic drugs which also leads to the preparation of nanomaterials for the delivery of antibiotics, anticancer, proteins, peptides and nucleic acids using several routes of administration. Recently, synthesis and research on polysaccharides based nanomaterials have gained enormous attention as one of the most applicable resources in nanomedicine area. This review article will provide a specific emphasis on polysaccharides as natural biomaterials for targeted anticancer drug delivery system.
- 19 April 2016
- Published by Taylor & Francis in Journal of Drug Targeting
- Vol. 25 (1) , 1-16
Polysaccharides based nanomaterials for targeted anti-cancer drug delivery
Polysaccharides, an important class of biological polymers, are effectively bioactive, non-toxic, hydrophilic, biodegradable and offer a wide diversity in structure and properties. These can be easily modified chemically and biochemically to enhance the bioadhesion with biological tissues, better stability and can able to improve bioavailability of drugs. Most of the chemotherapeutic drugs have a narrow therapeutic index, slow drug delivery systems and poor water solubility that usually proves toxic to human bodies. The inherent biocompatibility of these biopolymers have shown enhancement of solubility of some chemotherapeutic drugs which also leads to the preparation of nanomaterials for the delivery of antibiotics, anticancer, proteins, peptides and nucleic acids using several routes of administration. Recently, synthesis and research on polysaccharides based nanomaterials have gained enormous attention as one of the most applicable resources in nanomedicine area. This review article will provide a specific emphasis on polysaccharides as natural biomaterials for targeted anticancer drug delivery system.
- 30 January 2016
- Published by Springer Nature in Applied Microbiology and Biotechnology
- Vol. 100 (6) , 2603-2615
An update on polysaccharide-based nanomaterials for antimicrobial applications
Scientific community has made a lot of efforts to combat the infectious diseases using antimicrobial agents, but these are associated with problems of development of multi-drug resistance and their adverse side effects. To tackle these challenges, nanocarrier-based drug delivery system using polysaccharides has received enormous attention in the past few years. These antimicrobial agents can become more efficacious when adsorbed, entrapped, or linked to polysaccharides. In addition, these nanocarrier-based systems provide an increase in the surface area of the drug and are able to achieve the targeted drug delivery as well as used for the synthesis of packaging materials with improved mechanical strength, barrier, and antimicrobial properties. This review focuses on potential therapeutic applications of nanocarrier-based drug delivery systems using polysaccharides for antimicrobial applications.
- 30 January 2016
- Published by Springer Nature in Applied Microbiology and Biotechnology
- Vol. 100 (6) , 2603-2615
An update on polysaccharide-based nanomaterials for antimicrobial applications
Scientific community has made a lot of efforts to combat the infectious diseases using antimicrobial agents, but these are associated with problems of development of multi-drug resistance and their adverse side effects. To tackle these challenges, nanocarrier-based drug delivery system using polysaccharides has received enormous attention in the past few years. These antimicrobial agents can become more efficacious when adsorbed, entrapped, or linked to polysaccharides. In addition, these nanocarrier-based systems provide an increase in the surface area of the drug and are able to achieve the targeted drug delivery as well as used for the synthesis of packaging materials with improved mechanical strength, barrier, and antimicrobial properties. This review focuses on potential therapeutic applications of nanocarrier-based drug delivery systems using polysaccharides for antimicrobial applications.